Due to the lack of reliable commercial antibodies for Rab40b, we used a previously generated triple-negative breast cancer cell line MDA-MB-231 that stably expresses FLAG-Rab40b (Jacob et al., 2013). This evidence concerns the gene RAB40B and triple-negative breast carcinoma.